Updated:
GJS Capital
GJS Capital is a joint venture between Guotai Junan Investment Management and Shanghai Junzheng Investment, registered with the Asset Management Association of...
GJS Capital
GJS Capital is a joint venture between Guotai Junan Investment Management and Shanghai Junzheng Investment, registered with the Asset Management Association of China. The firm has made one investment. In October 2022, GJS Capital invested in Medaxis as part of its Series A - II round.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Frequently asked questions
What is GJS Capital's investment strategy?
GJS Capital pursues a stage-agnostic private equity strategy, deploying capital from seed rounds through growth equity. This suggests the firm can enter early and follow on across subsequent rounds, though specific sector concentrations and check sizes are not publicly disclosed.
Who makes investment decisions at GJS Capital?
The firm has not publicly disclosed its principals, investment committee members, or decision-making structure. Its low public profile in Shanghai's private equity ecosystem leaves the leadership team and governance framework unconfirmed in available sources.
Is GJS Capital a fund or a deal-by-deal investment vehicle?
GJS Capital's legal and fund structure has not been publicly detailed. Given its classification as a private equity firm in China, it may operate through a standard GP-LP fund model, but this remains unverified without official disclosures or regulatory filings surfacing publicly.
Which sectors does GJS Capital target?
Sector preferences have not been disclosed in publicly available materials. The absence of a thematic or sector-specific mandate in its known descriptions suggests the firm may maintain a generalist approach, though this is an inference drawn from limited data rather than confirmed policy.
How long has GJS Capital been operating?
The founding year of GJS Capital is not publicly known. The firm does not appear to have a substantial presence in major English-language or Chinese-language private equity databases, which limits the ability to establish its track record or vintage.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: